Characteristics (mean and SEM or frequency and percentage) of all participants
| Baseline | End of intervention | 2½ Years | 4 Years | |||||
|---|---|---|---|---|---|---|---|---|
| INT | CON | INT | CON | INT | CON | INT | CON | |
| N | 78 | 81 | 75 | 80 | 50 | 52 | 45 | 50 |
| Age, mean (SEM) | 54.4 (0.42) | 54.1 (0.41) | ||||||
| BMI, mean (SEM) | 26.4 (0.45) | 27.2 (0.50) | 25.2 (0.53) | 26.2 (0.62) | 26.0 (0.56) | 26.6 (0.79) | ||
| Use of medicine in the past 7 days | ||||||||
| Hormone replacement therapy, N (%) | 2 (2.6) | 1 (2.8) | 5 (6.7) | 2 (2.5) | 10 (20.4) | 12 (24.5) | 14 (31.1) | 8 (16.0) |
| Blood pressure and cholesterol medicine, N (%) | 16 (20.5) | 12 (14.8) | 12 (18.8) | 12 (17.9) | 13 (26.5) | 16 (32.7) | 10 (22.2) | 11 (22.0) |
| Headache medicine and other painkillers, sedatives and sleeping pills, and antidepressants, N (%) | 43 (55.1) | 33 (40.7) | 32 (50.0) | 38 (56.7) | 25 (51.0) | 29 (59.2) | 14 (31.1) | 14 (28.0) |
| Vitamin and mineral supplements, N (%) | 43 (55.1) | 42 (51.9) | 39 (60.9) | 36 (53.7) | 28 (57.1) | 32 (65.3) | 31 (68.9) | 17 (34.0) |
BMI, body mass index; CON, control; INT, intervention.